PRDM9 and cancer: SMYD3 is a histone methyltransferase that contributes to the development and progression of multiple types of cancers, and we analyzed SMYD3 mRNA expression and protein expression in renal tumors and adjacent normal tissues from both our data and publicly available gene expression profile data (e.g., the GEO and Oncomine databases).